NCT02771340 2020-10-01Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal MelanomaIconic Therapeutics, Inc.Phase 1 Completed10 enrolled 10 charts
NCT00000124 2006-06-02Collaborative Ocular Melanoma Study (COMS)National Eye Institute (NEI)Phase 3 Unknown